Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
241-255 of 350
Examining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Clinician's RoundtableExamining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Slowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
On the Frontlines of Prostate CancerSlowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
William Aronson, MD
Early-Stage Prostate Cancer Treatment: Examining Long-Term Complications
On the Frontlines of Prostate CancerEarly-Stage Prostate Cancer Treatment: Examining Long-Term Complications
Joseph Unger, PhD, MS
Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Project Oncology®Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Charles Turck, PharmD, BCPS, BCCCP
Matthew Hadfield, MD
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
- advertisement
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Project Oncology®Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
- advertisement
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
On the Frontlines of Prostate CancerProstate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Tanya Dorff, MD
Patient-Centered Insights for Advanced Prostate Cancer Treatment
On the Frontlines of Prostate CancerPatient-Centered Insights for Advanced Prostate Cancer Treatment
Tanya Dorff, MD
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®Exercise in Multiple Myeloma: Balancing Benefits and Safety
Jens Hillengass, MD, PhD
